Tango Therapeutics (TNGX) News Today $6.82 +0.29 (+4.44%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$6.82 +0.00 (+0.07%) As of 09/15/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TNGX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Recommendation of "Buy" by AnalystsSeptember 14 at 4:10 AM | marketbeat.comJacobs Levy Equity Management Inc. Purchases 220,529 Shares of Tango Therapeutics, Inc. $TNGXSeptember 14 at 3:26 AM | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Trading Down 6.7% on Insider SellingSeptember 12, 2025 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Stock Price Down 6.7% After Insider SellingSeptember 12, 2025 | americanbankingnews.comTango Therapeutics (NASDAQ:TNGX) Major Shareholder Sells $608,671.36 in StockSeptember 11, 2025 | marketbeat.comRock Ventures Iv L.P. Third Sells 642,906 Shares of Tango Therapeutics (NASDAQ:TNGX) StockSeptember 11, 2025 | marketbeat.comInsider Selling: Tango Therapeutics (NASDAQ:TNGX) Major Shareholder Sells 86,459 Shares of StockSeptember 10, 2025 | insidertrades.comTango Therapeutics, Inc. $TNGX Stake Cut by American Century Companies Inc.September 9, 2025 | marketbeat.comNuveen LLC Purchases New Shares in Tango Therapeutics, Inc. $TNGXSeptember 8, 2025 | marketbeat.comWalleye Capital LLC Sells 75,255 Shares of Tango Therapeutics, Inc. $TNGXSeptember 6, 2025 | marketbeat.comRussell Investments Group Ltd. Buys 49,116 Shares of Tango Therapeutics, Inc. $TNGXSeptember 6, 2025 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Trading Down 5.1% - Time to Sell?September 5, 2025 | marketbeat.comADAR1 Capital Management LLC Makes New Investment in Tango Therapeutics, Inc. $TNGXSeptember 5, 2025 | marketbeat.comNantahala Capital Management LLC Acquires 183,573 Shares of Tango Therapeutics, Inc. $TNGXSeptember 3, 2025 | marketbeat.comSiren L.L.C. Sells 38,555 Shares of Tango Therapeutics, Inc. $TNGXAugust 31, 2025 | marketbeat.comAlgert Global LLC Cuts Position in Tango Therapeutics, Inc. $TNGXAugust 28, 2025 | marketbeat.comRock Ventures Iv L.P. Third Sells 302,194 Shares of Tango Therapeutics (NASDAQ:TNGX) StockAugust 27, 2025 | insidertrades.comTango Therapeutics to Participate in the 2025 Cantor Global Healthcare ConferenceAugust 26, 2025 | globenewswire.comTango Therapeutics (NASDAQ:TNGX) Major Shareholder Sells $7,711,000.00 in StockAugust 22, 2025 | insidertrades.comTango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Rating of "Buy" by BrokeragesAugust 20, 2025 | marketbeat.comPiper Sandler Initiates Coverage of Tango Therapeutics (TNGX) with Overweight RecommendationAugust 19, 2025 | msn.comTango Therapeutics initiated with an Overweight at Piper SandlerAugust 19, 2025 | msn.comPiper starts Tango Therapeutics with an Overweight on TNG462 potentialAugust 19, 2025 | msn.comB. Riley Raises Earnings Estimates for Tango TherapeuticsAugust 14, 2025 | marketbeat.comTango Therapeutics, Inc. (NASDAQ:TNGX) Shares Acquired by XTX Topco LtdAugust 14, 2025 | marketbeat.comCantor Fitzgerald Analysts Lift Earnings Estimates for TNGXAugust 9, 2025 | marketbeat.comQ3 EPS Estimate for Tango Therapeutics Lifted by AnalystAugust 8, 2025 | marketbeat.comGuggenheim Boosts Tango Therapeutics (NASDAQ:TNGX) Price Target to $10.00August 7, 2025 | marketbeat.comTango (TNGX) Q2 Revenue Drops 52%August 5, 2025 | fool.comTango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business HighlightsAugust 5, 2025 | globenewswire.comTango Therapeutics (NASDAQ:TNGX) Trading Up 7.1% - What's Next?August 2, 2025 | marketbeat.comTango Therapeutics (TNGX) to Release Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Up 3% - Should You Buy?July 24, 2025 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Stock Price Up 9.1% - Time to Buy?July 18, 2025 | marketbeat.comTNGX - Tango Therapeutics Inc News - MorningstarJuly 16, 2025 | morningstar.comMTango Therapeutics (NASDAQ:TNGX) Shares Down 4.6% - Time to Sell?July 11, 2025 | marketbeat.comHC Wainwright Issues Positive Estimate for TNGX EarningsJuly 2, 2025 | marketbeat.comTango Therapeutics doses first patient in cancer drug combo trialJune 29, 2025 | uk.investing.comTango Therapeutics, Inc. (NASDAQ:TNGX) Receives Average Rating of "Buy" from AnalystsJune 28, 2025 | marketbeat.comTango Therapeutics Shares Climb After First Patient Dosed in Pancreatic, Lung Cancer TrialJune 27, 2025 | marketwatch.comTango Therapeutics (NASDAQ:TNGX) Trading Up 6.5% - Should You Buy?June 27, 2025 | marketbeat.comTango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines' Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung CancerJune 27, 2025 | globenewswire.comTango Therapeutics (NASDAQ:TNGX) Shares Down 8.3% - Should You Sell?June 25, 2025 | marketbeat.comTango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last? - NasdaqJune 25, 2025 | nasdaq.comExchange Traded Concepts LLC Purchases 47,901 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX)June 25, 2025 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Up 4.7% - What's Next?June 17, 2025 | marketbeat.comTango Therapeutics’ SWOT analysis: stock poised for growth amid clinical trialsJune 16, 2025 | investing.comTango Therapeutics (NASDAQ:TNGX) Shares Down 7.4% - Here's What HappenedJune 13, 2025 | marketbeat.comTango Therapeutics (NASDAQ:TNGX) Shares Gap Down - Time to Sell?June 12, 2025 | marketbeat.comB. Riley Expects Higher Earnings for Tango TherapeuticsJune 12, 2025 | marketbeat.com Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TNGX Media Mentions By Week TNGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNGX News Sentiment▼0.870.94▲Average Medical News Sentiment TNGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNGX Articles This Week▼113▲TNGX Articles Average Week Get the Latest News and Ratings for TNGX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Tango Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies RARE News Today TLX News Today NAMS News Today VKTX News Today XENE News Today AMRX News Today SRRK News Today IMVT News Today MOR News Today HCM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNGX) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tango Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tango Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNGX Stock Alerts